Class I Histone Deacetylase Inhibition for the Treatment of Sustained Atrial Fibrillation
暂无分享,去创建一个
S. Houser | F. Recchia | P. Jadiya | Tao Wang | Geeta Chacko | M. Seki | V. Patel | Christine N. Vrakas | R. Berretta | J. Arkles | Ryan LaCanna | J. Copper | Jian-lin Huang | J. Powers | Fang Liu | John Holten | Remus M. Berretta
[1] Jiening Xiao,et al. Atrial Fibrillation Activates AMP-Dependent Protein Kinase and its Regulation of Cellular Calcium Handling: Potential Role in Metabolic Adaptation and Prevention of Progression. , 2015, Journal of the American College of Cardiology.
[2] L. Zentilin,et al. Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy. , 2015, Journal of the American College of Cardiology.
[3] K. Clément,et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. , 2015, European heart journal.
[4] M. Lu,et al. GATA-Binding Factor 6 Contributes to Atrioventricular Node Development and Function , 2015, Circulation. Cardiovascular genetics.
[5] Shih‐Ann Chen,et al. Histone deacetylase inhibition reduces pulmonary vein arrhythmogenesis through calcium regulation. , 2014, International journal of cardiology.
[6] V. Vieira-Potter. Inflammation and macrophage modulation in adipose tissues , 2014, Cellular microbiology.
[7] L. Leng,et al. The vestigial enzyme D-dopachrome tautomerase protects the heart against ischemic injury. , 2014, The Journal of clinical investigation.
[8] S. Houser,et al. The Gut Hormone Ghrelin Partially Reverses Energy Substrate Metabolic Alterations in the Failing Heart , 2014, Circulation. Heart failure.
[9] C. Fiset,et al. Interleukin-1β Reduces L-type Ca2+ Current through Protein Kinase Cϵ Activation in Mouse Heart* , 2014, The Journal of Biological Chemistry.
[10] M. Zoni-Berisso,et al. Epidemiology of atrial fibrillation: European perspective , 2014, Clinical epidemiology.
[11] A. Yıldırım,et al. Increased level of resistin predicts development of atrial fibrillation. , 2014, Journal of cardiology.
[12] E. Kholmovski,et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. , 2014, JAMA.
[13] C. Chiang,et al. Clinical Characteristics, Management, and Control of Permanent vs. Nonpermanent Atrial Fibrillation: Insights from the RealiseAF Survey , 2014, PloS one.
[14] F. Hoogstra-Berends,et al. Activation of Histone Deacetylase-6 Induces Contractile Dysfunction Through Derailment of &agr;-Tubulin Proteostasis in Experimental and Human Atrial Fibrillation , 2014, Circulation.
[15] D. Tsiantoulas,et al. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction , 2013, Nature Medicine.
[16] Christina E. Wells,et al. HDAC3 is essential for DNA replication in hematopoietic progenitor cells. , 2013, The Journal of clinical investigation.
[17] C. Apovian,et al. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile , 2013, Proceedings of the National Academy of Sciences.
[18] Shuai Li,et al. Simvastatin attenuates sympathetic hyperinnervation to prevent atrial fibrillation during the postmyocardial infarction remodeling process. , 2012, Journal of applied physiology.
[19] G. Lip,et al. Inflammation in atrial fibrillation. , 2012, Journal of the American College of Cardiology.
[20] Shih‐Ann Chen,et al. Adipocytes modulate the electrophysiology of atrial myocytes: implications in obesity-induced atrial fibrillation , 2012, Basic Research in Cardiology.
[21] P. Kirchhof,et al. An Introduction to Murine Models of Atrial Fibrillation , 2012, Front. Physio..
[22] K. Yoshimoto,et al. The Action of D-Dopachrome Tautomerase as an Adipokine in Adipocyte Lipid Metabolism , 2012, PloS one.
[23] F. Mehrani,et al. Perioperative intravenous corticosteroids reduce incidence of atrial fibrillation following cardiac surgery: a randomized study. , 2012, Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular.
[24] S. Baldus,et al. Inflammatory pathways underlying atrial fibrillation. , 2011, Trends in molecular medicine.
[25] S. Grandy,et al. Reduction of Ventricular Sodium Current in a Mouse Model of HIV , 2010, Journal of cardiovascular electrophysiology.
[26] V. Patel,et al. An evaluation of transmitral and pulmonary venous Doppler indices for assessing murine left ventricular diastolic function. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[27] T. Golub,et al. Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease , 2010, Proceedings of the National Academy of Sciences.
[28] H. Kohler,et al. Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. , 2010, Genes & development.
[29] E. Olson,et al. Redundant Control of Adipogenesis by Histone Deacetylases 1 and 2* , 2010, The Journal of Biological Chemistry.
[30] Y. Iwasaki,et al. Recruitment of immune cells across atrial endocardium in human atrial fibrillation. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[31] G. Naccarelli,et al. Increasing prevalence of atrial fibrillation and flutter in the United States. , 2009, The American journal of cardiology.
[32] S. Grandy,et al. Ventricular K+ currents are reduced in mice with elevated levels of serum TNFalpha. , 2009, Journal of molecular and cellular cardiology.
[33] Zhao-Jun Liu,et al. Trafficking and differentiation of mesenchymal stem cells , 2009, Journal of cellular biochemistry.
[34] J. Epstein,et al. Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin. , 2008, Journal of molecular and cellular cardiology.
[35] 小柳 俊哉,et al. 59) 非細菌性心内膜炎の2手術例(第104回日本循環器学会九州地方会) , 2008 .
[36] Daniele Coin,et al. Long-Term Clinical Results of 2 Different Ablation Strategies in Patients With Paroxysmal and Persistent Atrial Fibrillation , 2008, Circulation. Arrhythmia and electrophysiology.
[37] L. Jonasson,et al. Source of inflammatory markers in patients with atrial fibrillation. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[38] T. Murohara,et al. Circulating adiponectin levels in patients with atrial fibrillation. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[39] L. Leng,et al. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart , 2008, Nature.
[40] Richard Pazdur,et al. FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. , 2007, The oncologist.
[41] G. Morley,et al. Cardiac-Specific Loss of N-Cadherin Leads to Alteration in Connexins With Conduction Slowing and Arrhythmogenesis , 2005, Circulation research.
[42] C. Monneret. Histone deacetylase inhibitors. , 2005, European journal of medicinal chemistry.
[43] J. Epstein,et al. Homeobox Protein Hop Functions in the Adult Cardiac Conduction System , 2005, Circulation research.
[44] H. Calkins,et al. Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation , 2005, Circulation. Arrhythmia and electrophysiology.
[45] R. Schilsky,et al. A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[46] J. Nemunaitis,et al. Phase I Study of Oral CI-994 in Combination with Carboplatin and Paclitaxel in the Treatment of Patients with Advanced Solid Tumors , 2004, Cancer investigation.
[47] S. Nattel,et al. Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs With Ventricular Tachypacing–Induced Congestive Heart Failure , 2001, Circulation.
[48] W. Colucci,et al. Interleukin-1β and Tumor Necrosis Factor-α Decrease Collagen Synthesis and Increase Matrix Metalloproteinase Activity in Cardiac Fibroblasts In Vitro , 2000 .
[49] C. Akdis,et al. Human B cells secrete migration inhibition factor (MIF) and present a naturally processed MIF peptide on HLA‐DRB1*0405 by a FXXL motif , 1999, Immunology.
[50] K. Walsh,et al. Preclinical toxicity of a new oral anticancer drug, CI-994 (Acetyldinaline), in rats and dogs , 2004, Investigational New Drugs.
[51] W. Colucci,et al. Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. , 2000, Circulation research.